(RTTNews) - Achieve Life Sciences, Inc. (ACHV), a late-stage specialty pharmaceutical company, said on Thursday that it has appointed Benjamin Halladay as chief financial officer with effect from October 5. He will succeed Mark Oki, who will step down as CFO on the same day.
Mostramos publicamente o ponto principal. Crie uma conta gratuita para continuar lendo o artigo completo, salva-lo, comenta-lo e conecta-lo ao contexto de mercado e OSINT.